BIOTECH Patent News articles from September 1 2007

BIOTECH Patent News archives from September 1 2007

University of Wyoming obtains United States patent.
September 1, 2007... University of Wyoming (Laramie, WY) has patented methods for expressing spider silk proteins in plants and the synthesis and purification of spider silk proteins therefrom. (US 7,288,391)

Ajinomoto obtains United States patent.
September 1, 2007... Ajinomoto Co., Inc. (Tokyo, Japan) has patented DNA and recombinant DNA that encode a peptide-forming enzyme, a method for producing a peptide-forming enzyme, and a method for producing a dipeptide. A method for producing a dipeptide includes...

Degussa obtains United States patent.
September 1, 2007... Degussa AG (Dusseldorf, Germany) has patented a Rhodococcus polynucleotide cluster which contains nucleotide sequences which encode polypeptides having the activity of a nitrile hydratase, of an auxiliary protein P15K which activates this...

ProChon obtains United States patent.
September 1, 2007... ProChon Biotech Ltd. (Rehovot, Israel) has patented active fibroblast growth factor variants demonstrating enhanced receptor subtype specificity. The preferred novel variants retain binding to FGF Receptor Type 3 (FGFR3) triggering...

Monsanto obtains United States patent.
September 1, 2007... Monsanto Technology LLC (St. Louis, MO) has patented nucleic acid molecules that encode amino acid transporters in a plant, and complements and fragments thereof. Also set forth herein are methods for using such nucleic acid molecules for the...

Celtrix obtains United States patent.
September 1, 2007... Celtrix Pharmaceuticals, Inc. (Richmond, VA) has patented methods for the treatment of cancer are provided. Null IGF (IGF variants with reduced receptor binding) is administered to subjects having cancer, thereby alleviating the symptoms of the...

University of Southern California obtains United States patent.
September 1, 2007... University of Southern California (Los Angeles, CA) has patented methods, compounds, pharmaceutical compositions, and kits for the augmentation of erythropoiesis by potentiating erythropoietin-induced differentiation with angiotensinogen,...

University of Maryland obtains United States patent.
September 1, 2007... University of Maryland Biotechnology Institute (Rockville, MD) and University of Maryland (Baltimore, MD) has patented homogeneous phase enzyme-catalyzed processes for producing modified chitosan polymers or oligomers. An enzyme is reacted with...

Euroscreen obtains United States patent.(Brief article)
September 1, 2007... Euroscreen, s.a. (Gosselies, Belgium) has patented an isolated G-protein coupled receptor, nucleic acid sequence encoding the receptor, and host cells capable of expressing the receptor. The invention further comprises methods for detecting the...

Monsanto obtains United States patent.
September 1, 2007... Monsanto Technology LLC (St. Louis, MO) has patented compositions and methods that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are...

Michigan Technological University obtains United States patent.
September 1, 2007... Michigan Technological University (Houghton, MI) has patented a novel DNA sequence, which encodes a previously unidentified lignin biosynthetic pathway enzyme, sinapyl alcohol dehydrogenase (SAD) that regulates the biosynthesis of syringyl...

MacroChem acquires rights to pexiganan for treatment of diabetic foot infections.
September 1, 2007... MacroChem Corporation (Wellesley Hills, MA) exercised the option it acquired in July, 2007 to acquire exclusive worldwide license rights for drug uses of pexiganan, a novel, small peptide anti-infective for treatment of patients with mild...

Aida granted additional anti-cancer patent.
September 1, 2007... Aida Pharmaceuticals, Inc. (Santa Monica, CA), one of mainland China's leading pharmaceutical companies, announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been...

Pharmacopeia acquires selective androgen receptor modulator program from Bristol-Myers.
September 1, 2007... Pharmacopeia (Princeton, CA), an innovator in the discovery and development of novel small molecule therapeutics, announced that it has licensed from Bristol-Myers Squibb (New York, NY) a selective androgen receptor modulator (SARM) program,...

Human Pheromone files patent application for wellness compound.(Human Pheromone Sciences, Inc.)(Brief article)
September 1, 2007... Human Pheromone Sciences, Inc. (San Jose, CA) announced that it filed a provisional patent application with the United States Patent and Trademark Office for the use of a novel compound found in nature which has significant positive impacts on...

Salugen announces partnership with DNA Dimensions.
September 1, 2007... Salugen, Inc. (San Diego, CA), a leading personalized healthcare company, announces a partnership with DNA Dimensions of Southfield, Michigan to distribute Salugen's nutritional gene testing and DNA-customized nutritional solutions in metro...

Orchid Cellmark to purchase ReliaGene.
September 1, 2007... Orchid Cellmark, Inc. (Princeton, NJ), a leading worldwide provider of identity DNA testing services, announced that it has signed a definitive purchase agreement to acquire the outstanding stock of ReliaGene Technologies, Inc. (New Orleans,...

Martek wins German patent infringement actions against Lonza.
September 1, 2007... Martek Biosciences Corporation (Columbia, MD) announced that a three-judge panel of a district court in Dusseldorf, Germany, has orally announced a judgment in favor of Martek in the company's patent infringement suit against (i) Lonza Ltd.,...

Organizations from all 50 states speak out against proposed patent reform act.
September 1, 2007... Senate leaders received a letter bearing the names of more than 430 organizations and companies united in opposition to the Patent Reform Act of 2007 as currently written. Spanning a vast range of industries and\ including every size of entity...

National Stem in final stage negotiations for exclusive licensing of its recently discovered biomaterial for anti-aging applications.
September 1, 2007... National Stem Cell Holding, Inc. (Moutainside, NJ) announced that it is currently in final stage negotiations to exclusively license one of its recently discovered biomaterials which holds promise as an effective anti- aging agent and...

Arius announces new findings in Trop-2 and CD59 CANCER antibody programs - CD59 antibody uses novel approach to "de-cloak" cancers -.
September 1, 2007... ARIUS Research Inc., (Toronto, Canada), a biotechnology company discovering and developing the next wave of antibody therapeutics, announced that new findings have been presented from its Trop-2 and CD59 antibody programs. "Both our Trop-2...

Sigma-Aldrich and Oxford BioMedica win key ruling in open biosystems patent Infringement dispute.
September 1, 2007... Sigma-Aldrich (St. Louis, MO), a life science company dedicated to providing state-of-the-art chemical and biotechnology products to the world's researchers, and Oxford BioMedica (Oxford, England), a leading gene therapy company, announced that...

Quest Diagnostics licenses technology underlying SensiTrop HIV co-receptor tropism test from pathway diagnostics -First national diagnostic testing company to license proprietary technology-.
September 1, 2007... Quest Diagnostics Incorporated (Madison, NJ), the nation's leading provider of diagnostic testing, information and services, announced that it has entered into a non- exclusive license agreement for the heteroduplex tracking technology...

New United States patent granted for Nventa's Coval HPV fusions to treat patients with HPV-related diseases.
September 1, 2007... Nventa Biopharmaceuticals Corporation (San Diego, CA) announced that the United States Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a...

WellGen proceeds to build pipeline of patented nutraceuticals and advance product development programs.
September 1, 2007... WellGen, Inc. (North Brunswick, NJ), a biotechnology company using nutrigenomics to discover and develop food ingredients for wellness products, announced the completion of its Series C financing totaling $9.5 million. The capital raised from...

Xenomics announces license with Asuragen for NPM1 leukemia diagnostics.
September 1, 2007... Xenomics, Inc. (New York, NY) has granted Asuragen, Inc. co-exclusive worldwide rights to incorporate NPM1 technology into Asuragen's molecular diagnostic products. Under the terms of this agreement, Asuragen will have the right to develop,...

Bovaird & Co. obtains United States patent.(Bovaird Supply Co.)(Brief article)
September 1, 2007... Bovaird & Co. (Tulsa, OK) has patented a method of managing organic waste and an organic waste management system. The method includes the steps of receiving organic waste liquids and solids in a collection vessel, such as a grease trap. The...

BASF obtains United States patent.
September 1, 2007... BASF Plant Science GmbH (Germany) has patented cyanobacteria as an alternative source of ahas and pds genes for plant transformations and for selectable markers. In particular, it provides for cyanobacteria, for example, Synechocystis, as a...

Canadian Forest Service obtains United States patent.(Brief article)
September 1, 2007... Canadian Forest Service (Canada) has patented an isolated polynucleotide sequence useful as a promoter in plant root tissue. The sequence is derived from the promoter for the Western white pine gene PR10. The sequence comprises at least 45...